Species distribution and antifungal susceptibilities of bloodstream Candida isolates: a nine-years single center survey
- 25 June 2020
- journal article
- research article
- Published by Taylor & Francis in Journal of Chemotherapy
- Vol. 32 (5) , 244-250
Abstract
This study analyzed the epidemiology of bloodstream infections due to Candida spp. in a tertiary referral hospital of Ancona, Italy, and their susceptibility to antifungals. The retrospective observational study from January 2010 to December 2018 identified 504 episodes of candidemia in 461 patients. Although Candida albicans remained the species most frequently isolated, Candida spp. other than C. albicans caused 49% of the overall episodes of candidemia. According to CLSI interpretation, most of the isolates resulted susceptible to antifungals. Azoles vs Candida tropicalis represented an exception. Echinocandin non-susceptibility was rare across the species. In conclusion, with the exception of C. tropicalis, the isolation of a non-susceptible Candida strains against azoles, echinocandins and amphotericin B was a rare event.Keywords
This publication has 25 references indexed in Scilit:
- Executive Summary: Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2016
- Antifungal Susceptibility Profiles of Bloodstream Yeast Isolates by Sensititre YeastOne over Nine Years at a Large Italian Teaching HospitalAntimicrobial Agents and Chemotherapy, 2015
- Clinical and Therapeutic Aspects of Candidemia: A Five Year Single Centre StudyPLOS ONE, 2015
- The Effect on Mortality of Fluconazole or Echinocandins Treatment in Candidemia in Internal Medicine WardsPLOS ONE, 2015
- Comparative Evaluation of a New Commercial Colorimetric Microdilution Assay (SensiQuattro Candida EU) with MIC Test Strip and EUCAST Broth Microdilution Methods for Susceptibility Testing of Invasive Candida IsolatesJournal of Clinical Microbiology, 2015
- Update on antifungal resistance in Aspergillus and CandidaClinical Microbiology and Infection, 2014
- Recent Exposure to Caspofungin or Fluconazole Influences the Epidemiology of Candidemia: a Prospective Multicenter Study Involving 2,441 PatientsAntimicrobial Agents and Chemotherapy, 2011
- Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and Candida: Time for harmonization of CLSI and EUCAST broth microdilution methodsDrug Resistance Updates, 2010
- Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2009
- Has Antifungal Susceptibility Testing Come of Age?Clinical Infectious Diseases, 2002